Screener
Sana Biotechnology SANA Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| General and administrative | 11,462 | 11,484 |
| Total operating expenses | 48,614 | 50,630 |
| Loss from operations | (48,614) | (50,630) |
| Interest income, net | 951 | 992 |
| Other income, net | 453 | 249 |
| Net loss | $(47,210) | $(49,389) |
| Net loss per common share – basic and diluted | $(0.17) | $(0.21) |
| Weighted-average number of common shares – basic and diluted | 276,856 | 237,578 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's interest expense?
- Sana Biotechnology (SANA) reported interest expense of $951K in Q1 2026.
- How has Sana Biotechnology's interest expense changed year-over-year?
- Sana Biotechnology's interest expense decreased by 4.1% year-over-year, from $992K to $951K.
- What is the long-term trend for Sana Biotechnology's interest expense?
- Over 4 years (2021 to 2025), Sana Biotechnology's interest expense has grown at a 54.5% compound annual growth rate (CAGR), from $676K to $3.85M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Sana Biotechnology's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude